Ad Scientiam:企業の製品パイプライン分析

◆英語タイトル:Ad Scientiam - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2362711PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ad Scientiam is a medical technology company that offers digital biomarkers which collects physiological and behavioral data. It provides mobile application which monitors patients’ behaviors and sharers the data to healthcare professionals. Ad Scientiam serves individuals, healthcare professionals and pharmaceutical companies. The company’s solution finds application in the areas of Parkinson disease, Asthma, Atopic Dermatisi, Insomnia, Multiple Sclerosis, Oncology and Alzheimer’s disease among others. It also operates an office in the US. Ad Scientiam is headquartered in Paris, Ile de France, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Ad Scientiam
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Ad Scientiam Company Overview
Ad Scientiam Company Snapshot
Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam – Pipeline Analysis Overview
Ad Scientiam – Key Facts
Ad Scientiam – Major Products and Services
Ad Scientiam Pipeline Products by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Pipeline Products Overview
Actisleep
Actisleep Product Overview
CARDICARE
CARDICARE Product Overview
CARDICARE Clinical Trial
Mobile Application – Alzheimer’s
Mobile Application – Alzheimer’s Product Overview
Mobile Application – Asthma
Mobile Application – Asthma Product Overview
Mobile Application – Insomnia
Mobile Application – Insomnia Product Overview
Mobile Application – Major Depressive Disorder
Mobile Application – Major Depressive Disorder Product Overview
Mobile Application – Major Depressive Disorder Clinical Trial
Mobile Application – Oncology
Mobile Application – Oncology Product Overview
Mobile Application – Parkinson’s
Mobile Application – Parkinson’s Product Overview
Mobile Application – Rheumatoid Arthritis
Mobile Application – Rheumatoid Arthritis Product Overview
Mobile Application – Schizophrenia
Mobile Application – Schizophrenia Product Overview
MSCopilot Mobile App
MSCopilot Mobile App Product Overview
Ad Scientiam – Key Competitors
Ad Scientiam – Key Employees
Ad Scientiam – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Ad Scientiam, Recent Developments
Oct 28, 2019: Ad Scientiam tracks valuable digital biomarkers for clinical research
Jan 29, 2019: Ad Scientiam selected for Pfizer Acceleration Program
Nov 14, 2018: Ad Scientiam announces clinical validation of its MSCopilot solution
Nov 14, 2018: Ad Scientiam, a french startup hosted at the Brain & Spine Institute (paris), announces clinical validation of its MSCopilot solution
Jul 18, 2018: MyHBP, application dedicated to the monitoring of benign prostatic hypertrophy
Jul 18, 2018: TLM : new version of MSCopilot
Jul 17, 2018: Ad Scientiam selected for EIT Health GoGlobal Canada Programme
Jun 08, 2018: Altran accompanies Ad Scientiam on the European compliance of MSCopilot
Jun 01, 2018: The 16 Health start-ups selected by Product Market Fit
May 30, 2018: MSCopilot is evolving for World MS Day
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Ad Scientiam Pipeline Products and Ongoing Clinical Trials Overview
Ad Scientiam Pipeline Products by Equipment Type
Ad Scientiam Pipeline Products by Indication
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam, Key Facts
Ad Scientiam, Major Products and Services
Ad Scientiam Number of Pipeline Products by Development Stage
Ad Scientiam Pipeline Products Summary by Development Stage
Ad Scientiam Ongoing Clinical Trials by Trial Status
Ad Scientiam Ongoing Clinical Trials Summary
Actisleep - Product Status
Actisleep - Product Description
CARDICARE - Product Status
CARDICARE - Product Description
CARDICARE - Impact of a Digital Solution (CardiCare) on Cardiorespiratory Fitness Improvement in Patients Discharged from a Phase 2 Cardiac Rehabilitation Following an Acute Coronary Syndrome
Mobile Application - Alzheimer’s - Product Status
Mobile Application - Alzheimer’s - Product Description
Mobile Application - Asthma - Product Status
Mobile Application - Asthma - Product Description
Mobile Application - Insomnia - Product Status
Mobile Application - Insomnia - Product Description
Mobile Application - Major Depressive Disorder - Product Status
Mobile Application - Major Depressive Disorder - Product Description
Mobile Application - Major Depressive Disorder - Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
Mobile Application - Oncology - Product Status
Mobile Application - Oncology - Product Description
Mobile Application - Parkinson’s - Product Status
Mobile Application - Parkinson’s - Product Description
Mobile Application - Rheumatoid Arthritis - Product Status
Mobile Application - Rheumatoid Arthritis - Product Description
Mobile Application - Schizophrenia - Product Status
Mobile Application - Schizophrenia - Product Description
MSCopilot Mobile App - Product Status
MSCopilot Mobile App - Product Description
Ad Scientiam, Key Employees
Ad Scientiam, Other Locations
Glossary

★海外企業調査レポート[Ad Scientiam:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Concordia International Corp (CXR)-製薬・医療分野:企業M&A・提携分析
    Summary Concordia International Corp (Concordia), formerly Concordia Healthcare Corp is a healthcare products provider that offers orphan drugs. The company undertakes the management and acquisition of legacy pharmaceutical products, orphan drugs and medical devices for diabetics. Its products compr …
  • PFM Packaging Machinery S.p.a.:企業の戦略・SWOT・財務情報
    PFM Packaging Machinery S.p.a. - Strategy, SWOT and Corporate Finance Report Summary PFM Packaging Machinery S.p.a. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Accugenomics Inc:企業の製品パイプライン分析
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Xspray Pharma AB (XSPRAY):製薬・医療:M&Aディール及び事業提携情報
    Summary Xspray Pharma AB (Xspray Pharma), formerly Xspray Microparticles AB, is a drug development company that develops and commercializes protein kinase inhibitors (PKI) for targeted cancer treatments. The company’s drug candidates include HyNap-Dasa, HyNap-Nilo and HyNap-Sora. Its protein kinase …
  • Merck KGaA (MRK):医療機器:M&Aディール及び事業提携情報
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • Maxeda B.V.:戦略・SWOT・企業財務分析
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報
    Summary GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epider …
  • Traverse Energy Ltd (TVL):石油・ガス:M&Aディール及び事業提携情報
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …
  • Norwegian Energy Company ASA:企業のM&A・事業提携・投資動向
    Norwegian Energy Company ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Norwegian Energy Company ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Anglo American South Africa Limited:企業の戦略・SWOT・財務情報
    Anglo American South Africa Limited - Strategy, SWOT and Corporate Finance Report Summary Anglo American South Africa Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Atterx Biotherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Atterx Biotherapeutics Inc (Atterx), formerly ConjuGon Inc is a developer of novel products for prevention and treatment of antibiotic-resistant bacterial infections. The company develops and commercializes conjugation-based antibacterial technology. Its products include C-1205 and GN-4474. …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Doosan Heavy Industries & Construction Co Ltd (034020)-エネルギー分野:企業M&A・提携分析
    Summary Doosan Heavy Industries & Construction Co., Ltd. (Doosan Heavy Industries), a subsidiary of Doosan Corporation, is a power plant equipment manufacturer. It offers integrated equipment and solutions for power and water plants. The company’s major products include boilers, generators, engines, …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Top Kinisis Travel Public Ltd:戦略・SWOT・企業財務分析
    Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Tutunski Kombinat AD Prilep:企業の戦略・SWOT・財務分析
    Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report Summary Tutunski Kombinat AD Prilep - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Centrica Plc (CNA):電力:M&Aディール及び事業提携情報
    Summary Centrica Plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Somnomed Ltd (SOM):医療機器:M&Aディール及び事業提携情報
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆